Tier 1 — highest

Response of Vitamin D after Magnesium Intervention in a Postmenopausal Population from the Province of Granada, Spain

Héctor Vázquez-Lorente, Lourdes Herrera-Quintana, Jorge Molina-López, Yenifer Gamarra-Morales, Beatriz López-González, Claudia Miralles-Adell, Elena Planells
Nutrients 2020 12(8):2283

Bibliography

PubMed
PMID 32751522
PubMed Central
PMC7468838
Funding
Funding is not specified in the indexed abstract or accessible funding metadata. Consult the original publication for the declaration.
Competing interests
The authors report no relevant competing interests.

Study snapshot

DesignRandomized controlled clinical trial
ModelHuman participants
Sample52 postmenopausal women aged 44–76
Intervention500 mg/day magnesium as reported by the authors, versus placebo
Duration8 weeks
EndpointsSerum vitamin D status

What the study showed, in plain terms

This publication examines serum vitamin d status. Study population or evidence base: 52 postmenopausal women aged 44–76. Intervention or exposure: 500 mg/day magnesium as reported by the authors, versus placebo.

Key findings

Magnesium supplementation increased vitamin D concentrations relative to placebo in this small postmenopausal sample. More than four fifths of participants had deficient vitamin D status at baseline.

What this study can and cannot tell us

A small biomarker study in one population. The indexed abstract does not clarify the magnesium salt or whether the stated amount is elemental magnesium.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Biohack Blueprint Research